Fintel reports that on January 29, 2025, Cantor Fitzgerald upgraded their outlook for Beam Therapeutics (NasdaqGS:BEAM) from ...
Each year, Cantor Fitzgerald and BGC donate 100 percent of their global ... Mariano Rivera, Willie Randolph, Dwight Doc Gooden, Olympic gold medallist winners Bode Miller and Mikaela Shiffrin and ...
President-elect Donald Trump on Tuesday nominated Cantor Fitzgerald CEO Howard Lutnick to serve as commerce secretary. Lutnick, 63, has served as the co-chair of Trump's transition team and was a ...
Investment firm Cantor Fitzgerald recently penned a research ... Shares were likely range-bound into DOC/BIS announcement, ...
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Free Report) – Investment analysts at Cantor Fitzgerald issued their FY2025 earnings per share estimates for shares of Crinetics Pharmaceuticals ...
Cantor Fitzgerald raised the firm’s price target on CyberArk (CYBR) to $415 from $335 and keeps an Overweight rating on the shares. The firm is bullish on the Venafi opportunity, and thinks the ...
Cantor Fitzgerald raised the firm’s price target on Rubrik (RBRK) to $85 from $70 and keeps an Overweight rating on the shares. Rubrik has performed well since its April 2024 IPO, and its ...